Potential role for statins in the treatment of chronic HCV infection

被引:4
|
作者
Zhu, Qianqian [1 ]
Han, Qunying [1 ]
Liu, Zhengwen [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Infect Dis, Xian 710061, Shaanxi Provinc, Peoples R China
关键词
chronic hepatitis C; direct-acting antiviral; host-targeting agent; IFN-; ribavirin; statin; treatment; CHRONIC HEPATITIS-C; VIRUS-RNA REPLICATION; PEGYLATED INTERFERON; COMBINATION THERAPY; ANTIVIRAL EFFICACY; PLUS RIBAVIRIN; GENOTYPE; 1B; OPEN-LABEL; FLUVASTATIN; RESISTANCE;
D O I
10.2217/fvl.13.70
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:727 / 729
页数:3
相关论文
共 50 条
  • [31] Traditional Chinese medicine in the treatment of chronic HCV infection.
    Metzner, MK
    Maulayah, P
    Benshemesh, C
    Cramp, ME
    HEPATOLOGY, 2002, 36 (04) : 569A - 569A
  • [32] Advances in the treatment of chronic HCV infection with direct acting antivirals
    Sulkowski, Mark
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 74 : 67 - 67
  • [33] Mechanism of action of ribavirin in the combination treatment of chronic HCV infection
    Lau, JYN
    Tam, RC
    Liang, TJ
    Hong, Z
    HEPATOLOGY, 2002, 35 (05) : 1002 - 1009
  • [34] Boceprevir: an oral protease inhibitor for the treatment of chronic HCV infection
    Trembling, Paul M.
    Tanwar, Sudeep
    Dusheiko, Geoffrey M.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (03) : 269 - 279
  • [35] PERSISTENCE OF HCV VIREMIA IN CHRONIC HCV INFECTION
    LOK, ASF
    CHEUNG, R
    CHAN, R
    HEPATOLOGY, 1992, 16 (02) : 563 - 563
  • [36] Celgosivir, an α-glucosidase I inhibitor for the potential treatment of HCV infection
    Durantel, David
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (08) : 860 - 870
  • [37] Intrahepatic HCV levels in chronic HCV infection
    Bonacini, M
    Redeker, AG
    GUT, 1999, 45 (04) : 630 - 630
  • [38] The Potential Role of Statins in Pneumonia
    Nakashima, Brandy
    Restrepo, Marcos I.
    Anzueto, Antonio
    Mortensen, Eric M.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2010, 6 (03) : 155 - 161
  • [39] Putative role of chronic HCV infection in the development of cirrhotic cardiomyopathy.
    Ratti, L
    Redaelli, E
    Guidi, C
    Milanese, M
    Pozzi, M
    HEPATOLOGY, 2005, 42 (04) : 408A - 408A
  • [40] In vitro and in vivo evaluation of HCV polymerase inhibitors as potential drug candidates for treatment of chronic hepatitis C infection
    Ilan, E
    Zauberman, A
    Aviel, S
    Nussbaum, O
    Arazi, E
    Ben-Moshe, O
    Slama, D
    Tzionas, I
    Shoshany, Y
    Lee, SW
    Han, JJ
    Park, SJ
    Lee, GH
    Park, EY
    Shin, JC
    Suh, JW
    Kim, JW
    Dagan, S
    ANTIVIRAL RESEARCH, 2004, 62 (02) : A83 - A83